The following abstract will be presented at the 2009 Joint Meeting of the Society for Neuro-Oncology and the AANS/CNS Section on Tumors:
Links to data available at time of presentation.
| Abstract Number |
Abstract
Title |
Presentation
Date & Time (CDT) |
| 599 |
A Phase 2 Study of XL184, an Inhibitor of MET, VEGFR2, and RET, in Patients with Progressive Glioblastoma Multiforme (GBM)
Data |
Friday, October 23
5:15 - 7:15p.m. |
